BeStock  
Stocks › Biotechnology › TRVI

Trevi Therapeutics TRVI

US equityMarket cap rank #2705Biotechnology
$13.35 −$0.37 (-2.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.35 0.00%
Open$13.58
Prev close$13.72
Day range$13.23 – $13.90
Volume2.09M
Market cap$1.90B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$27.71+107.6% vs. price
  • Buy 100%
Low $23.00Now $13.35Avg $27.71High $36.00

Recent rating changes

The last 20 actions on file set price targets from $23.00 to $40.00, averaging $27.95.

DateFirmRatingTarget
10 Nov 2026 JonesTrading BUY $28.00
10 Nov 2026 Morgan Stanley BUY $23.00
10 Nov 2026 Stifel BUY $30.00
10 Nov 2026 Needham BUY $23.00
10 Nov 2026 BMO Capital BUY $36.00
10 Nov 2026 H.C. Wainwright BUY $24.00
9 Nov 2026 Cantor Fitzgerald BUY $30.00
22 Oct 2026 JonesTrading BUY $28.00
6 Oct 2026 BMO Capital BUY $36.00
21 Sep 2026 H.C. Wainwright BUY $24.00
13 Aug 2026 JonesTrading BUY $28.00
11 Aug 2026 H.C. Wainwright BUY $24.00
10 Aug 2026 Morgan Stanley BUY $23.00
7 Aug 2026 Raymond James BUY $40.00
7 Aug 2026 Morgan Stanley BUY $23.00
7 Aug 2026 Stifel BUY $30.00
7 Aug 2026 Needham BUY $23.00
7 Aug 2026 B. Riley Securities BUY $31.00
7 Aug 2026 Oppenheimer BUY $25.00
6 Aug 2026 Cantor Fitzgerald BUY $30.00

Discussion

No comments yet — be the first to weigh in on TRVI.

Sign in to join the discussion.

Scroll to Top